scanX
Home
Sequent Scientific

Sequent Scientific

225.29
-6.93
(-2.98%)
Market Cap (₹ Cr.)
₹5,803
52 Week High
237.85
Book Value
₹26
52 Week Low
90.65
PE Ratio
318.49
PB Ratio
8.84
PE for Sector
38.75
PB for Sector
4.65
ROE
-16.28 %
ROCE
-0.72 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-3.27 %
Net Income Growth
75.72 %
Cash Flow Change
82.03 %
ROE
74.49 %
ROCE
93.40 %
EBITDA Margin (Avg.)
307.72 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
107
110
116
88
95
91
97
39
39
39
45
31
427
31
41
51
57
54
59
64
65
58
78
74
75
52
61
65
69
71
61
65
55
50
59
56
50
69
Expenses
109
94
104
77
84
85
90
38
35
32
32
32
32
27
36
47
53
49
49
56
52
47
64
56
67
51
55
56
58
67
64
66
53
56
57
46
43
60
EBITDA
-3
16
12
11
12
6
7
1
4
6
13
-1
395
4
5
4
4
5
10
8
14
11
15
18
9
2
6
8
11
4
-3
-1
2
-6
2
9
7
9
Operating Profit %
-19 %
9 %
6 %
2 %
8 %
2 %
2 %
-31 %
-30 %
-24 %
-23 %
-20 %
-21 %
-3 %
-0 %
3 %
4 %
6 %
5 %
9 %
17 %
16 %
12 %
18 %
4 %
-9 %
-9 %
5 %
8 %
-3 %
-18 %
-15 %
-13 %
-38 %
-16 %
-10 %
-16 %
-3 %
Depreciation
6
5
5
6
8
6
6
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
2
3
2
2
2
2
2
2
2
2
2
2
2
Interest
10
7
3
3
4
2
2
0
0
0
0
0
0
0
0
1
2
1
1
1
1
1
1
1
0
0
0
1
1
0
1
1
1
1
1
1
1
1
Profit Before Tax
-19
4
4
3
-0
-2
-1
-1
3
6
12
-2
393
3
3
1
0
1
7
5
10
8
12
16
6
-1
3
6
8
1
-6
-4
-1
-9
-1
6
4
6
Tax
2
0
0
0
0
0
0
0
0
0
0
1
2
0
1
0
-1
0
0
1
2
2
1
3
1
-0
-2
1
1
0
-0
-1
1
-2
2
0
0
1
Net Profit
-20
4
4
3
-0
-2
-1
-1
3
6
12
-2
391
3
3
1
1
1
10
3
7
6
10
12
5
-1
4
4
7
1
-4
-1
-2
-7
-1
5
4
5
EPS in ₹
-6.64
0.89
1.06
0.12
-0.01
-0.08
-0.03
-0.03
0.14
0.23
0.50
-0.10
16.14
0.11
0.11
0.04
0.06
0.06
0.42
0.12
0.28
0.25
0.39
0.48
0.19
-0.02
0.17
0.18
0.27
0.03
-0.16
-0.05
-0.07
-0.27
-0.04
0.18
0.15
0.18
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
650
1,348
1,450
977
1,019
997
1,102
1,124
1,123
1,188
Fixed Assets
201
176
188
24
52
69
66
67
57
43
Current Assets
242
301
368
141
86
112
119
146
75
97
Capital Work in Progress
9
20
32
3
0
4
4
1
2
5
Investments
0
891
891
687
788
758
685
659
633
640
Other Assets
441
262
340
264
178
167
347
397
431
500
Total Liabilities
493
143
193
29
101
111
73
83
64
100
Current Liabilities
427
110
169
27
79
93
70
81
62
98
Non Current Liabilities
66
33
24
2
22
18
2
3
3
2
Total Equity
157
1,206
1,257
949
918
886
1,030
1,041
1,058
1,087
Reserve & Surplus
126
1,158
1,209
900
868
837
980
991
1,008
1,037
Share Capital
30
48
49
49
49
50
50
50
50
50
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
7
-12
0
-0
0
2
-2
12
-13
1
Investing Activities
24
-359
-47
16
-114
-18
17
-4
-51
5
Operating Activities
-25
100
-24
-4
74
30
2
9
38
-27
Financing Activities
8
247
71
-12
40
-11
-21
7
0
22
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
53.86 %
53.86 %
53.52 %
53.02 %
53.02 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.78 %
FIIs
13.15 %
13.60 %
14.12 %
6.42 %
5.84 %
6.45 %
6.57 %
6.25 %
5.90 %
6.26 %
6.03 %
6.12 %
6.16 %
5.70 %
DIIs
3.21 %
2.48 %
2.04 %
2.13 %
2.04 %
2.26 %
2.79 %
2.81 %
2.92 %
2.92 %
3.23 %
7.23 %
7.59 %
8.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.17 %
29.46 %
29.73 %
37.89 %
38.60 %
38.10 %
37.47 %
37.76 %
38.01 %
37.64 %
37.57 %
33.70 %
33.29 %
33.29 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
77.34
ATR(14)
Volatile
12.11
STOCH(9,6)
Overbought
84.27
STOCH RSI(14)
Overbought
91.42
MACD(12,26)
Bullish
4.53
ADX(14)
Strong Trend
44.02
UO(9)
Bearish
60.00
ROC(12)
Uptrend But Slowing Down
26.43
WillR(14)
Neutral
-21.31
Bearish
5
Neutral
2
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.